• Skip to primary navigation
  • Skip to main content
  • Skip to footer
IQ Consortium

IQ Consortium

Organization of pharmaceutical and biotechnology companies with a mission of advancing science and technology.

  • About Us
  • IQ Publications
  • Events
  • Login

#pediatricformulations

Best Industry Practices for the Qualification of Food Vehicles in Drug Administration

May 19, 2025 by Maja Leah Marshall

Presented by the Pediatric Working Group
Sponsored by the Drug Product Leadership Group

Speakers: Anna Externbrink, MSD and and Yemin Liu, AbbVie
Moderator: Elizabeth Galella, Bristol Myers Squibb

The use of soft foods and liquids as vehicles for drug administration can significantly enhance palatability and acceptability in pediatric patients, thereby improving therapeutic outcomes. In vitro assessments are employed to identify and qualify food vehicles for drug product labeling; however, interpreting and applying regulatory guidance in this area can be challenging.

This webinar aims to provide pharmaceutical R&D professionals and regulators with a scientific framework for justifying food vehicles in drug administration while facilitating the development of clear and meaningful label instructions. Attendees will gain insights into best industry practices, supported by case studies and practical examples.

This is a public webinar. Membership in the IQ Consortium is not required to attend.

Tagged With: #drugproduct, #pediatricformulations, IQConsortium, IQWebinar

Unmet Medical Needs for Pediatric Drug Development: A Clinical Perspective

May 19, 2025 by Maja Leah Marshall

Presented by the Pediatric Working Group
Sponsored by the Drug Product Leadership Group

Speaker: Mary Short
Moderator: Elizabeth Galella, Bristol Myers Squibb

(Description forthcoming)

This is a public webinar. Membership in the IQ Consortium is not required to attend.

Tagged With: #drugproduct, #pediatricformulations, IQConsortium, IQWebinar

Making Bitter Medicines Better for Everyone

April 3, 2025 by Maja Leah Marshall

* New Date*

Presented by the Pediatric Working Group
Sponsored by the Drug Product Leadership Group

People vary widely in how bitter they perceive medicines to be, which can impact how easily they take them. A global study from the Monell Chemical Senses Center found that genetic ancestry influences how bitter certain medicines taste and how well sweeteners or other modifiers reduce bitterness. For example, a common sweetener worked better for some groups than others, which has important implications for making medicines more palatable for children and adults alike. By understanding these differences, pharmaceutical companies can develop better formulations that improve medication adherence, particularly in pediatric and global health settings where taking every dose is critical.

Tagged With: #drugproduct, #pediatricformulations, #tastemasking, IQConsortium, IQWebinar

Footer

Privacy Policy

Terms of Use

  • LinkedIn
  • Mail

Copyright © 2025 IQ Consortium